The American Diabetes Association® (ADA) applauds Alabama Medicaid for updating its coverage to expand access to continuous glucose monitoring (CGM) technology. This change marks a critical step forward in improving diabetes care and health outcomes for Alabamians living with diabetes.
CGMs consistently monitor blood glucose (blood sugar) levels, giving real-time updates through a device that is attached to a person’s body. People with diabetes who use a CGM have fewer instances of hypoglycemia (low blood glucose) and can achieve a lower A1C, an important indicator of overall diabetes management.
The benefits of CGMs include:
- Help in avoiding or delaying serious, short- and long-term diabetes complications
- Potential reduced hospitalizations
- Potential cost savings through improved diabetes management
- Fewer adverse diabetes events
Under the new coverage policy, effective Oct. 1st, adults with type 1 diabetes are now covered, as are people with type 2 diabetes who administer insulin multiple times a day.
The ADA thanks Alabama Medicaid for recognizing the value of CGM technology in improving diabetes management, preventing complications, reducing hospitalizations, and preventing the unnecessary medical costs affiliated with poor outcomes.
###
About the American Diabetes Association
The American Diabetes Association (ADA) is the nation’s leading voluntary health organization fighting to end diabetes and helping people thrive. This year, the ADA celebrates 85 years of driving discovery and research to prevent, manage, treat, and ultimately cure diabetes—and we’re not stopping. There are 136 million Americans living with diabetes or prediabetes. Through advocacy, program development, and education, we’re fighting for them all. To learn more or to get involved, visit us at or call 1-800-DIABETES (800-342-2383). Join us in the fight on Facebook (American Diabetes Association), Spanish Facebook (Asociación Americana de la Diabetes), LinkedIn (American Diabetes Association), and Instagram (@AmDiabetesAssn). To learn more about how we are advocating for everyone affected by diabetes, visit us on X (@AmDiabetesAssn).
